Prakiraan wutah bathi resik saben saham kanggo taun ngarep Portage (PRTG)

Logo korporat perusahaan Portage Biotech Inc. (PRTG)

Adherence to ethical standards and ESG principles ensures the sustainability of Portage Biotech Inc. (PRTG). A shift in the consensus growth estimate for net income confirms this status, where 0.00 serves as the current parameter value. The development of universal iNKT platforms to combat metastases complements the growth trajectory, yet a critical capital shortage and the threat of liquidation remain key risk factors.

Portage (PRTG): Prakiraan wutah bathi resik saben saham kanggo taun ngarep saka 04.07.2022 nganti 04.09.2025

Ringkesan rincian data analitis portagebiotech.com (PRTG)

- rega saham lan konsensus proyeksi valuasi:
Analisis fundamental perusahaan:Portage
Produk dadi Portage Biotech Inc

This indicator reflects the consensus forecast for earnings per share growth rates, measuring the gap between current market expectations and historical values. By analyzing the expected EPS dynamics for the next period, an investor can assess the probability of Portage Biotech Inc. (PRTG) capitalization through the success of immuno-oncology drug clinical trials or a potential acquisition by a strategic pharma behemoth.

Analisis pesaing Portage Biotech Inc.

INCY (Incyte Corp.) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi saben saham kanggo taun ngarep HUTCHMED Corp (HCM)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Nuvation Bio Inc. (NUVB)|DAWN - Prakiraan wutah bathi resik saben saham ing taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Monopar Therapeutics Inc. MNPR|Inhibrx - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|IMAB - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Fennec|HRTX: Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben siji saham kanggo taun ngarep nuvectis.com NVCT|Prakiraan wutah bathi saben saham kanggo taun ngarep CHRS|Prakiraan wutah bathi resik saben saham ing taun ngarep Corbus Pharmaceuticals Holdings, Inc. CRBP|Prakiraan wutah bathi saben saham kanggo taun ngarep CRDF (Cardiff Oncology, Inc.)|BYSI (BeyondSpring Inc) - Dinamika bathi saben saham sing diarepake ing taun ngarep|BioAtla - Prakiraan wutah bathi saben saham kanggo taun ngarep|Proyeksi tambahing bathi saben saham ing taun ngarep LIXT (lixte.com)|Citius Pharma - Prakiraan wutah bathi kanggo taun ngarep|Dinamika bathi saben saham sing diarepake ing taun ngarep CLRB (Cellectar Biosciences Inc)|BLRX: Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Can-Fite (CANF)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Aprea Therapeutics Inc.|KZIA: Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi kanggo taun ngarep SLXN|Prakiraan wutah bathi kanggo taun ngarep nucana.com (NCNA)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Chimerix, Inc CMRX|CYCC (Cyclacel, Inc.) - Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep|GTHX: Prakiraan wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep kronosbio.com|Kintara Therapeutics, Inc. (KTRA) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep ONCT (Oncternal Therapeutics Inc)